Cancer News and Research

Latest Cancer News and Research

Support for securing health insurance for all Americans

A diverse group of local organizations has come together to demonstrate its support for securing health insurance for all Americans, including the nearly 44 million uninsured Americans, among them 400,000 in Tampa Bay.

8 May 2004

SWHR urges women to learn about their unique health issues

Cardiovascular disease kills 50,000 more American women than men each year and women who smoke are more likely than men to develop two of the worst types of lung cancer. National Women's Health Week is May 9-15 and the Society for Women's Health Research (SWHR) urges women to learn how their unique biological makeup affects the prevention, diagnosis and treatment of these and many other diseases.

8 May 2004

Measurable improvements in productivity throughout the NHS

NHS Chief Executive, Sir Nigel Crisp today reported that sustained improvements to services for patients were being accelerated, with measurable improvements in productivity throughout the NHS.

8 May 2004

Prostatectomy may decrease male orgasmic quality

The first longitudinal study of male orgasmic quality following radical retropubic prostatectomy (RRP) found that some men experience decreased orgasmic quality.

8 May 2004

New way by which cells can become cancerous may solve mystery with lung cancer

Researchers at The University of Texas M. D. Anderson Cancer Center are describing an entirely new way by which cells can become cancerous. And they say their finding provides an answer to a mystery in lung and other cancers.

8 May 2004

Lab calibration errors may add $199 million to U.S. health care costs

Small measurement uncertainties in clinical laboratory tests can add large amounts to health care costs, according to a newly released study commissioned by the National Institute of Standards and Technology (NIST).

7 May 2004

West Nile treatment showing 100% response rate among immunocompetent patients

GenoMed, Inc. has announced that it will be limiting its treatment for West Nile virus encephalitis to immunocompetent patients only, where it has posted a 100% success rate.

7 May 2004

Researchers find an entirely new way by which cells can become cancerous

Finding provides an answer to a mystery in lung and other cancers: why a potent tumor suppressor gene called FUS1 functions as it should, yet none of the protein it produces can be found anywhere in a cancer cell.

6 May 2004

Kodak forms JV with NZ researchers for world’s first non-invasive digital imaging breast screening technique

The multi-national Eastman Kodak Company is forming a joint venture company with researchers at the University of Canterbury, to develop the world’s first non-invasive digital imaging breast screening technique.

6 May 2004

Launch of myDNA.com breast cancer channel

The myDNA.com Breast Cancer Channel integrates multi-cultural, relevant health information related to medications, clinical trials, support groups, leading hospitals, clinics, healthcare providers, and genetic, genomic and gene expression tests.

6 May 2004

Despite spending more for health care, Americans do not have the best medical care in the world

Despite spending more for health care, Americans do not have the best medical care in the world, according to researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions.

6 May 2004

The First International Congress on Antioxidant Methods

The First International Congress on Antioxidant Methods will be held June 16-18 in Orlando, Fla., in an effort to reach agreement on techniques for measuring and reporting on antioxidants, beneficial compounds found in foods, cosmetics and certain vitamins that are believed to fight cancer, heart disease and aging.

6 May 2004

A second-generation targetted antibody for potential cancer therapy

The overproduction, or 'overexpression', of the epidermal growth factor receptor (EGFR) is one of the most common aberrations in cancer, and subsequently agents that inhibit EGFR are among the most hotly-pursued potential products in the pharmaceutical industry.

6 May 2004

Cervical Dysplasia treatment linked to water breaking too early

Two treatments for removing precancerous tissue from the cervix are associated with an increased risk of preterm delivery (delivery before 37 weeks gestation) caused by the pregnancy complication known as preterm premature rupture of membranes (PPROM).

5 May 2004

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

A new international study of children with a severe form of acute lymphoblastic leukemia (ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.

5 May 2004

World's first gene therapy trial aimed at preventing cancer

The concept seems straightforward. If, at its heart, cancer is a disease of genes, then giving patients new genes should disarm cancer. Such treatment would replace missing or faulty genes that keep cell growth in check, or would flush the body with "super genes" that could attack and destroy cancer.

5 May 2004

Prevention and partnerships are the keys to improving health and reducing chronic disease in the United States

Prevention and partnerships are the keys to improving health and reducing chronic disease in the United States and throughout the Americas, a Pan American Health Organization official said today.

5 May 2004

Swedish Medical Center has unveiled the world's most advanced mobile mammography center

Swedish Medical Center today unveiled the world's most advanced mobile mammography center. Known as the "Swedish Breast Care Express," the 64-foot self-contained coach features the latest full-field digital mammography equipment. And it will be the first unit to incorporate a complete rooftop satellite system for transmitting images remotely.

5 May 2004

Immtech signs agreement with CombinatoRx to test Immtech compounds as potential cancer treatment

Immtech International, Inc. announced today that it signed an agreement with CombinatoRx of Boston, Massachusetts to screen its lead aromatic cationic compounds, DB289 and DB75, for activity against various cancers.

5 May 2004

New studies put spotlight on replicative capacity of beta cells

Researchers at Harvard University and the Howard Hughes Medical Institute (HHMI) have discovered that insulin-producing beta cells in the pancreas that are attacked in type 1 diabetes are replenished through duplication of existing cells rather than through differentiation of adult stem cells.

5 May 2004

Cancer News and Research

Latest Cancer News and Research

Support for securing health insurance for all Americans

SWHR urges women to learn about their unique health issues

Measurable improvements in productivity throughout the NHS

Prostatectomy may decrease male orgasmic quality

New way by which cells can become cancerous may solve mystery with lung cancer

Lab calibration errors may add $199 million to U.S. health care costs

West Nile treatment showing 100% response rate among immunocompetent patients

Researchers find an entirely new way by which cells can become cancerous

Kodak forms JV with NZ researchers for world’s first non-invasive digital imaging breast screening technique

Launch of myDNA.com breast cancer channel

Despite spending more for health care, Americans do not have the best medical care in the world

The First International Congress on Antioxidant Methods

A second-generation targetted antibody for potential cancer therapy

Cervical Dysplasia treatment linked to water breaking too early

Study sheds new light on children with a severe form of acute lymphoblastic leukemia

World's first gene therapy trial aimed at preventing cancer

Prevention and partnerships are the keys to improving health and reducing chronic disease in the United States

Swedish Medical Center has unveiled the world's most advanced mobile mammography center

Immtech signs agreement with CombinatoRx to test Immtech compounds as potential cancer treatment

New studies put spotlight on replicative capacity of beta cells

Cancer Research - Second Edition eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in